Plain-English translation of NCT05855941 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying whether advanced imaging scans—including PET/CT and PET/MRI—can help doctors better understand and stage gynecological cancers (cervical, endometrial, and ovarian). The study has two parts: one that reviews past patient records and imaging from 2013–2022, and another that follows newly diagnosed patients going forward. The goal is to improve how doctors use imaging to plan the best treatment for each patient.
Current staging methods for gynecological cancers sometimes miss important information that imaging scans could reveal. This trial aims to show whether adding advanced imaging results to standard staging helps doctors catch cancer at the right stage, predict how patients will do, and plan more targeted treatments.
You likely qualify if…
You likely don't qualify if…
If you join the retrospective part, researchers will review your medical records and imaging scans from your cancer diagnosis and treatment already completed. If you join the prospective part (going forward), you would have imaging scans done (MRI, CT, or PET/CT) as part of your normal cancer workup, and researchers would track how your treatment works and what happens over time. No extra procedures beyond standard care are required; the study simply uses imaging and information that would already be part of planning your cancer treatment.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Sweden
Sponsor
Region Västerbotten
Collaborators
Umeå University
Enrollment target
~120 participants
Started
May 2023
Primary completion
May 2032
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in December 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Erika Figaro
Department of Radiation Sciences, Umea University/Radiology, Umea University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.